More than 100 pharmacies to write off the de-listing, the pharmaceutical retail industry to "change the day"?

"
Pharmaceutical Network Market Analysis: On July 6, the Guangdong Provincial Drug Administration forwarded the announcement of the Xiashan Market Bureau of Zhanjiang City on the cancellation of the Drug Business LicenseAccording to the Regulations of the Guangdong Food and Drug Administration on the Cancellation of Drug Business Licenses, from January 1, 2019 to June 30, 2020, the FDA has cancelled the Drug Business Licenses of 100 enterprises in accordance with the law, the announcement saidIt is reported that the 100 cancellation of the de-listing of enterprises, only a few are expired expiration was written off, most of them are enterprises apply for cancellationand on July 3, the Guangdong Provincial Drug Administration also forwarded a circular from the Yun'an District Market Supervision Authority of Yunfu City to cancel the Drug Business License, stating that it had written off the Drug Business License of three enterprises in accordance with the law, all of which belonged to the enterprise application for cancellationOn the same day, the Guangdong Provincial Drug Administration issued a notice on the cancellation of the Drug Business License, stating that it had cancelled the "Drug Business License" of six pharmaceutical enterprises in accordance with the lawthese data are only in July, guangdong Province since January this year, a number of pharmacies in Guangdong Province have applied for the cancellation of the "drug business license." Unusually, in addition to Guangdong, Jiangsu, Shandong, Henan, Guangdong, Sichuan, Chongqing, Shaanxi and many other places have recently had pharmacies to cancel their licenses to exit the marketin addition to opting to cancel their licenses, there are a number of pharmacies that choose to sellFor example, Liaoning Chengda announced on May 9 that it intends to transfer 100% of the shares of Chengda Fangyuan Pharmaceutical Group Co., Ltdheld by the company through a public listing bid on the Dalian Property ExchangeIt was valued at RMB1,859 millionIn the announcement, it said that the sale of pharmacies is to continuously enhance its sustainable development capacity, highlight the core industry, and further optimize the allocation of resourcesin the industry's view, from the overall environment, drugstores write off the phenomenon of de-listing has been commonWith the implementation of centralized procurement, drug prices further reduced, profit margin compression, coupled with increasingly strengthened supervision, limited operations, pharmacy survival space is constantly compressed, naturally will choose to sell securities de-listingIn addition, this year by the impact of the special period, coupled with manpower, rent, compliance costs and many other factors, many community pharmacies are accelerating the closure"Many pharmacies are not well-run, and they don't have much expertise in community marketing, door-to-door, medication guidance, and sooner or later they will be eliminated."will strictly implement classification in the future, according to the hierarchical management measures of retail pharmaciesIn the process of industry reshuffle, it can be said that the era of retail pharmacies lying down to make money is overIn the future, the scope of drugstore sales that do not meet the standard requirements will shrink, profitability will decline, and gradually be eliminatedcan be said that the pharmaceutical retail industry is about to "change the day"So where will the future of pharmaceutical retail companies go? At present, China's pharmacy retail market has been from high-speed growth to medium-speed or even medium-speed growth stagePharmaceutical division has gradually become the "new medical reform" of the future direction of development, pharmaceutical retail industry will go through a painful transition periodin this context, the industry recommends to relax the time to 3-5 years or even 10 years, with a long-term strategic perspective to view, operating China's pharmacy retail marketIn the short term, the strategy needs firm innovation, tactics to be flexible, flexible, retail pharmacies should strengthen the operation of pharmacies, and strive to improve the operation and management of pharmacies technology, improve the quality of practitioners, strengthen the management of practicing pharmacists, for the vast number of consumers to protect the safety of drug use